Myelodysplasia following aplastic anaemia-paroxysmal nocturnal haemoglobinuria syndrome after treatment with immunosuppression and G-CSF: evidence for the emergence of a separate clone

Br J Haematol. 1996 Sep;94(3):510-2. doi: 10.1046/j.1365-2141.1996.d01-1831.x.

Abstract

Myelodysplasia (MDS) and aplastic anaemia-paroxysmal nocturnal haemoglobinuria (AA/PNH) syndrome developed in a severe aplastic anaemia (AA) patient after treatment with immunosuppressive (IS) therapy. Glycosylphosphatidyl inositol (GPI)-linked proteins were determined, and during the AA/PNH phase, a high proportion of neutrophils were found to be negative, without clinical evidence of haemolysis. However, MDS developed with cytogenetic abnormalities of monosomy 7,9q- and a rearranged chromosome 6; the GPI-linked protein negative cells were completely replaced by positively expressing cells. This represents the emergence of a GPI-linked protein positive myelodysplasia clone arising separately from an AA/PNH clone.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Anemia, Aplastic / complications
  • Anemia, Aplastic / therapy*
  • Glycosylphosphatidylinositols / metabolism
  • Granulocyte Colony-Stimulating Factor / adverse effects*
  • Hemoglobinuria, Paroxysmal / etiology*
  • Humans
  • Immunosuppression Therapy / adverse effects*
  • Male
  • Monocytes / metabolism
  • Myelodysplastic Syndromes / etiology*
  • Neutrophils / metabolism
  • Syndrome

Substances

  • Glycosylphosphatidylinositols
  • Granulocyte Colony-Stimulating Factor